South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part…...
Trending
- Wave at GITEX Africa 2026: Accelerating innovation, financial inclusion, and technological ambition on the continent
- Tunisia: Ennakl Automobiles to pay a dividend of 30 million dinars for the year 2025
- Egypt: BP announces a new natural gas discovery in the Eastern Mediterranean
- CEMAC: Gabon, Cameroon, and Congo account for 80% of debt on the regional market
- DRC: $57.4 million raised on Treasury bonds, sustained growth in the foreign exchange market
- East Africa: Remittances threatened by tensions in the Middle East, warns the World Bank
- Ivory Coast: Zenith Bank opens a subsidiary in Abidjan
- Djibouti: Ismaïl Omar Guelleh re-elected for a sixth term with 97.81% of the vote
South African Aspen Pharmacare sells key Asia-Pacific operations for $1.6 billion
By Félix NZALÉ
Félix NZALÉ
Félix Nzalé is a Senegalese journalist with a deep passion for cultural issues. He led the "CULTURE" section of SUD QUOTIDIEN (SUD Communication Group) for 10 years. Holder of dual Master’s degrees in Sociology and Philosophy, he also holds a management diploma from the Institut Supérieur de Management (ISM) in Dakar. He has contributed to the development of editorial concepts for several newspapers in Dakar.
Add A Comment
About us
Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, give meaning to statistics….
Contact us: redaction@financialafrik.com